Welcome to our media centre, here you will find a range of resources including our press releases, news updates and information related to the conferences and events we attend each year.
These press releases and news updates are intended for media and investors only.
UPCOMING CONGRESS
22 - 25 FEBRUARY, 2026
CROI 2026 CONFERENCE
We are excited to attend The Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado. CROI is a prominent annual scientific meeting focused on the latest research in HIV/AIDS and related opportunistic infections.
25 FEBRUARY 2026
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen
25 FEBRUARY 2026
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing
24 FEBRUARY 2026
ViiV Healthcare reports long-acting injectable Cabenuva effectively maintains viral suppression in adolescents living with HIV, with >97% preferring injections over daily oral treatment
23 FEBRUARY 2026
ViiV Healthcare announces data showing switching to Dovato was associated with a lower proportion of steatotic liver disease versus Biktarvy for HIV-1 treatment
18 FEBRUARY 2026
ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM
19 DECEMBER 2025
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
27 OCTOBER 2025
ViiV Healthcare launches ‘Risk to Reasons’ initiative in the UK to empower women to take control of their HIV prevention choices
Media contacts
Media contact details for our global headquarters and USA. For press contacts in our local operating companies please visit our country websites.
If you have a media query please contact us
Global Press Office
Rachel Jaikaran
Head of Global Communications ViiV Healthcare
Tel: +44 7823 523 755
NP-GBL-HVX-COCO-220039 | February 2026
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
